Loading…
Mice Deficient in the IL-1β Activation Genes Prtn3, Elane, and Casp1 Are Protected Against the Development of Obesity-Induced NAFLD
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease. Inflammatory pathways contribute to disease pathogenesis; however, regulation of the underlying mechanism is not completely understood. IL-1β, a pro-inflammatory cytokine, participates in the development and...
Saved in:
Published in: | Inflammation 2020-06, Vol.43 (3), p.1054-1064 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c474t-62fd00dc3c39023c182405222ea5aebc3a71556b4a58b22c8fb75db2b81e04de3 |
---|---|
cites | cdi_FETCH-LOGICAL-c474t-62fd00dc3c39023c182405222ea5aebc3a71556b4a58b22c8fb75db2b81e04de3 |
container_end_page | 1064 |
container_issue | 3 |
container_start_page | 1054 |
container_title | Inflammation |
container_volume | 43 |
creator | Mirea, Andreea-Manuela Stienstra, Rinke Kanneganti, Thirumala-Devi Tack, Cees J. Chavakis, Triantafyllos Toonen, Erik J.M. Joosten, Leo A.B. |
description | Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease. Inflammatory pathways contribute to disease pathogenesis; however, regulation of the underlying mechanism is not completely understood. IL-1β, a pro-inflammatory cytokine, participates in the development and progression of NAFLD. To become bioactive, IL-1β requires enzymatic processing. Mechanisms that activate IL-1β include the classical NLRP3 inflammasome-caspase-1 and the neutrophil serine proteases, neutrophil elastase, and proteinase-3. Several studies have shown that both caspase-1 and the neutrophil serine proteases are important for NAFLD development. However, it is unknown whether these pathways interact and if they have a synergistic effect in promoting NAFLD. In the present study, we developed a novel and unique mouse model by intercrossing caspase-1/11 knockout mice with neutrophil elastase/proteinase-3 double knockout mice. Subsequently, these mice were examined regarding the development of high-fat diet–induced NAFLD. Our results show that mice deficient in caspase-1, neutrophil elastase, and proteinase-3 were protected from developing diet-induced weigh gain, liver steatosis, and adipose tissue inflammation when compared with controls. We conclude that pathways that process pro-IL-1β to bioactive IL-1β play an important role in promoting the development of NAFLD and obesity-induced inflammation. Targeting these pathways could have a therapeutic potential in patients with NAFLD. |
doi_str_mv | 10.1007/s10753-020-01190-4 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7280336</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2350093348</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-62fd00dc3c39023c182405222ea5aebc3a71556b4a58b22c8fb75db2b81e04de3</originalsourceid><addsrcrecordid>eNp9kc9u1DAQhyMEotvCC3BAlrj00MDYjuPkghTttmWlhXKAs-U4k62rrLPYzkq980Q8SJ8Jb7eUPwdOPsw3n2fml2WvKLylAPJdoCAFz4FBDpTWkBdPshkVkudMyPJpNgNeQs7rWh5lxyHcAEBVV_x5dsQZAJOUz7LvH61BssDeGosuEutIvEayXOX07gdpTLQ7He3oyCU6DOSzj46fkfNBOzwj2nVkrsOWksZjqo0RTcSONGttXYj3pgXucBi3m7187MlVi8HG23zpuskk9FNzsVq8yJ71egj48uE9yb5enH-Zf8hXV5fLebPKTSGLmJes7wA6ww2vgXFDK1aAYIyhFhpbw7WkQpRtoUXVMmaqvpWia1lbUYSiQ36SvT94t1O7wc6kmbwe1Nbbjfa3atRW_V1x9lqtx52SrALOyyQ4fRD48duEIaqNDQaH_TnGKSjGBUDNeVEl9M0_6M04eZfWU6ygUBa15JAodqCMH0Pw2D8OQ0HtQ1aHkFUKWd2HrIrU9PrPNR5bfqWaAH4AQiq5Nfrff_9H-xNLjrGm</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2410649730</pqid></control><display><type>article</type><title>Mice Deficient in the IL-1β Activation Genes Prtn3, Elane, and Casp1 Are Protected Against the Development of Obesity-Induced NAFLD</title><source>Springer Link</source><creator>Mirea, Andreea-Manuela ; Stienstra, Rinke ; Kanneganti, Thirumala-Devi ; Tack, Cees J. ; Chavakis, Triantafyllos ; Toonen, Erik J.M. ; Joosten, Leo A.B.</creator><creatorcontrib>Mirea, Andreea-Manuela ; Stienstra, Rinke ; Kanneganti, Thirumala-Devi ; Tack, Cees J. ; Chavakis, Triantafyllos ; Toonen, Erik J.M. ; Joosten, Leo A.B.</creatorcontrib><description>Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease. Inflammatory pathways contribute to disease pathogenesis; however, regulation of the underlying mechanism is not completely understood. IL-1β, a pro-inflammatory cytokine, participates in the development and progression of NAFLD. To become bioactive, IL-1β requires enzymatic processing. Mechanisms that activate IL-1β include the classical NLRP3 inflammasome-caspase-1 and the neutrophil serine proteases, neutrophil elastase, and proteinase-3. Several studies have shown that both caspase-1 and the neutrophil serine proteases are important for NAFLD development. However, it is unknown whether these pathways interact and if they have a synergistic effect in promoting NAFLD. In the present study, we developed a novel and unique mouse model by intercrossing caspase-1/11 knockout mice with neutrophil elastase/proteinase-3 double knockout mice. Subsequently, these mice were examined regarding the development of high-fat diet–induced NAFLD. Our results show that mice deficient in caspase-1, neutrophil elastase, and proteinase-3 were protected from developing diet-induced weigh gain, liver steatosis, and adipose tissue inflammation when compared with controls. We conclude that pathways that process pro-IL-1β to bioactive IL-1β play an important role in promoting the development of NAFLD and obesity-induced inflammation. Targeting these pathways could have a therapeutic potential in patients with NAFLD.</description><identifier>ISSN: 0360-3997</identifier><identifier>EISSN: 1573-2576</identifier><identifier>DOI: 10.1007/s10753-020-01190-4</identifier><identifier>PMID: 32002713</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adipose tissue ; Animals ; Biomedical and Life Sciences ; Biomedicine ; Caspase 1 - deficiency ; Caspase 1 - genetics ; Caspase-1 ; Diet, High-Fat - adverse effects ; Elastase ; Fatty liver ; High fat diet ; IL-1β ; Immunology ; Inflammasomes ; Interleukin-1beta - antagonists & inhibitors ; Interleukin-1beta - genetics ; Interleukin-1beta - metabolism ; Internal Medicine ; Leukocyte Elastase - deficiency ; Leukocyte Elastase - genetics ; Liver diseases ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Neutrophils ; Non-alcoholic Fatty Liver Disease - genetics ; Non-alcoholic Fatty Liver Disease - metabolism ; Non-alcoholic Fatty Liver Disease - prevention & control ; Obesity ; Obesity - genetics ; Obesity - metabolism ; Obesity - prevention & control ; Original ; Original Article ; Pathology ; Pharmacology/Toxicology ; Proteinase ; Proteinase 3 ; Rheumatology ; Serine ; Serine Endopeptidases - deficiency ; Serine Endopeptidases - genetics ; Steatosis ; Transcription activation</subject><ispartof>Inflammation, 2020-06, Vol.43 (3), p.1054-1064</ispartof><rights>The Author(s) 2020</rights><rights>The Author(s) 2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-62fd00dc3c39023c182405222ea5aebc3a71556b4a58b22c8fb75db2b81e04de3</citedby><cites>FETCH-LOGICAL-c474t-62fd00dc3c39023c182405222ea5aebc3a71556b4a58b22c8fb75db2b81e04de3</cites><orcidid>0000-0002-9297-9871</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32002713$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mirea, Andreea-Manuela</creatorcontrib><creatorcontrib>Stienstra, Rinke</creatorcontrib><creatorcontrib>Kanneganti, Thirumala-Devi</creatorcontrib><creatorcontrib>Tack, Cees J.</creatorcontrib><creatorcontrib>Chavakis, Triantafyllos</creatorcontrib><creatorcontrib>Toonen, Erik J.M.</creatorcontrib><creatorcontrib>Joosten, Leo A.B.</creatorcontrib><title>Mice Deficient in the IL-1β Activation Genes Prtn3, Elane, and Casp1 Are Protected Against the Development of Obesity-Induced NAFLD</title><title>Inflammation</title><addtitle>Inflammation</addtitle><addtitle>Inflammation</addtitle><description>Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease. Inflammatory pathways contribute to disease pathogenesis; however, regulation of the underlying mechanism is not completely understood. IL-1β, a pro-inflammatory cytokine, participates in the development and progression of NAFLD. To become bioactive, IL-1β requires enzymatic processing. Mechanisms that activate IL-1β include the classical NLRP3 inflammasome-caspase-1 and the neutrophil serine proteases, neutrophil elastase, and proteinase-3. Several studies have shown that both caspase-1 and the neutrophil serine proteases are important for NAFLD development. However, it is unknown whether these pathways interact and if they have a synergistic effect in promoting NAFLD. In the present study, we developed a novel and unique mouse model by intercrossing caspase-1/11 knockout mice with neutrophil elastase/proteinase-3 double knockout mice. Subsequently, these mice were examined regarding the development of high-fat diet–induced NAFLD. Our results show that mice deficient in caspase-1, neutrophil elastase, and proteinase-3 were protected from developing diet-induced weigh gain, liver steatosis, and adipose tissue inflammation when compared with controls. We conclude that pathways that process pro-IL-1β to bioactive IL-1β play an important role in promoting the development of NAFLD and obesity-induced inflammation. Targeting these pathways could have a therapeutic potential in patients with NAFLD.</description><subject>Adipose tissue</subject><subject>Animals</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Caspase 1 - deficiency</subject><subject>Caspase 1 - genetics</subject><subject>Caspase-1</subject><subject>Diet, High-Fat - adverse effects</subject><subject>Elastase</subject><subject>Fatty liver</subject><subject>High fat diet</subject><subject>IL-1β</subject><subject>Immunology</subject><subject>Inflammasomes</subject><subject>Interleukin-1beta - antagonists & inhibitors</subject><subject>Interleukin-1beta - genetics</subject><subject>Interleukin-1beta - metabolism</subject><subject>Internal Medicine</subject><subject>Leukocyte Elastase - deficiency</subject><subject>Leukocyte Elastase - genetics</subject><subject>Liver diseases</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Neutrophils</subject><subject>Non-alcoholic Fatty Liver Disease - genetics</subject><subject>Non-alcoholic Fatty Liver Disease - metabolism</subject><subject>Non-alcoholic Fatty Liver Disease - prevention & control</subject><subject>Obesity</subject><subject>Obesity - genetics</subject><subject>Obesity - metabolism</subject><subject>Obesity - prevention & control</subject><subject>Original</subject><subject>Original Article</subject><subject>Pathology</subject><subject>Pharmacology/Toxicology</subject><subject>Proteinase</subject><subject>Proteinase 3</subject><subject>Rheumatology</subject><subject>Serine</subject><subject>Serine Endopeptidases - deficiency</subject><subject>Serine Endopeptidases - genetics</subject><subject>Steatosis</subject><subject>Transcription activation</subject><issn>0360-3997</issn><issn>1573-2576</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kc9u1DAQhyMEotvCC3BAlrj00MDYjuPkghTttmWlhXKAs-U4k62rrLPYzkq980Q8SJ8Jb7eUPwdOPsw3n2fml2WvKLylAPJdoCAFz4FBDpTWkBdPshkVkudMyPJpNgNeQs7rWh5lxyHcAEBVV_x5dsQZAJOUz7LvH61BssDeGosuEutIvEayXOX07gdpTLQ7He3oyCU6DOSzj46fkfNBOzwj2nVkrsOWksZjqo0RTcSONGttXYj3pgXucBi3m7187MlVi8HG23zpuskk9FNzsVq8yJ71egj48uE9yb5enH-Zf8hXV5fLebPKTSGLmJes7wA6ww2vgXFDK1aAYIyhFhpbw7WkQpRtoUXVMmaqvpWia1lbUYSiQ36SvT94t1O7wc6kmbwe1Nbbjfa3atRW_V1x9lqtx52SrALOyyQ4fRD48duEIaqNDQaH_TnGKSjGBUDNeVEl9M0_6M04eZfWU6ygUBa15JAodqCMH0Pw2D8OQ0HtQ1aHkFUKWd2HrIrU9PrPNR5bfqWaAH4AQiq5Nfrff_9H-xNLjrGm</recordid><startdate>20200601</startdate><enddate>20200601</enddate><creator>Mirea, Andreea-Manuela</creator><creator>Stienstra, Rinke</creator><creator>Kanneganti, Thirumala-Devi</creator><creator>Tack, Cees J.</creator><creator>Chavakis, Triantafyllos</creator><creator>Toonen, Erik J.M.</creator><creator>Joosten, Leo A.B.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9297-9871</orcidid></search><sort><creationdate>20200601</creationdate><title>Mice Deficient in the IL-1β Activation Genes Prtn3, Elane, and Casp1 Are Protected Against the Development of Obesity-Induced NAFLD</title><author>Mirea, Andreea-Manuela ; Stienstra, Rinke ; Kanneganti, Thirumala-Devi ; Tack, Cees J. ; Chavakis, Triantafyllos ; Toonen, Erik J.M. ; Joosten, Leo A.B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-62fd00dc3c39023c182405222ea5aebc3a71556b4a58b22c8fb75db2b81e04de3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adipose tissue</topic><topic>Animals</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Caspase 1 - deficiency</topic><topic>Caspase 1 - genetics</topic><topic>Caspase-1</topic><topic>Diet, High-Fat - adverse effects</topic><topic>Elastase</topic><topic>Fatty liver</topic><topic>High fat diet</topic><topic>IL-1β</topic><topic>Immunology</topic><topic>Inflammasomes</topic><topic>Interleukin-1beta - antagonists & inhibitors</topic><topic>Interleukin-1beta - genetics</topic><topic>Interleukin-1beta - metabolism</topic><topic>Internal Medicine</topic><topic>Leukocyte Elastase - deficiency</topic><topic>Leukocyte Elastase - genetics</topic><topic>Liver diseases</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Neutrophils</topic><topic>Non-alcoholic Fatty Liver Disease - genetics</topic><topic>Non-alcoholic Fatty Liver Disease - metabolism</topic><topic>Non-alcoholic Fatty Liver Disease - prevention & control</topic><topic>Obesity</topic><topic>Obesity - genetics</topic><topic>Obesity - metabolism</topic><topic>Obesity - prevention & control</topic><topic>Original</topic><topic>Original Article</topic><topic>Pathology</topic><topic>Pharmacology/Toxicology</topic><topic>Proteinase</topic><topic>Proteinase 3</topic><topic>Rheumatology</topic><topic>Serine</topic><topic>Serine Endopeptidases - deficiency</topic><topic>Serine Endopeptidases - genetics</topic><topic>Steatosis</topic><topic>Transcription activation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mirea, Andreea-Manuela</creatorcontrib><creatorcontrib>Stienstra, Rinke</creatorcontrib><creatorcontrib>Kanneganti, Thirumala-Devi</creatorcontrib><creatorcontrib>Tack, Cees J.</creatorcontrib><creatorcontrib>Chavakis, Triantafyllos</creatorcontrib><creatorcontrib>Toonen, Erik J.M.</creatorcontrib><creatorcontrib>Joosten, Leo A.B.</creatorcontrib><collection>SpringerOpen</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Inflammation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mirea, Andreea-Manuela</au><au>Stienstra, Rinke</au><au>Kanneganti, Thirumala-Devi</au><au>Tack, Cees J.</au><au>Chavakis, Triantafyllos</au><au>Toonen, Erik J.M.</au><au>Joosten, Leo A.B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mice Deficient in the IL-1β Activation Genes Prtn3, Elane, and Casp1 Are Protected Against the Development of Obesity-Induced NAFLD</atitle><jtitle>Inflammation</jtitle><stitle>Inflammation</stitle><addtitle>Inflammation</addtitle><date>2020-06-01</date><risdate>2020</risdate><volume>43</volume><issue>3</issue><spage>1054</spage><epage>1064</epage><pages>1054-1064</pages><issn>0360-3997</issn><eissn>1573-2576</eissn><abstract>Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease. Inflammatory pathways contribute to disease pathogenesis; however, regulation of the underlying mechanism is not completely understood. IL-1β, a pro-inflammatory cytokine, participates in the development and progression of NAFLD. To become bioactive, IL-1β requires enzymatic processing. Mechanisms that activate IL-1β include the classical NLRP3 inflammasome-caspase-1 and the neutrophil serine proteases, neutrophil elastase, and proteinase-3. Several studies have shown that both caspase-1 and the neutrophil serine proteases are important for NAFLD development. However, it is unknown whether these pathways interact and if they have a synergistic effect in promoting NAFLD. In the present study, we developed a novel and unique mouse model by intercrossing caspase-1/11 knockout mice with neutrophil elastase/proteinase-3 double knockout mice. Subsequently, these mice were examined regarding the development of high-fat diet–induced NAFLD. Our results show that mice deficient in caspase-1, neutrophil elastase, and proteinase-3 were protected from developing diet-induced weigh gain, liver steatosis, and adipose tissue inflammation when compared with controls. We conclude that pathways that process pro-IL-1β to bioactive IL-1β play an important role in promoting the development of NAFLD and obesity-induced inflammation. Targeting these pathways could have a therapeutic potential in patients with NAFLD.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>32002713</pmid><doi>10.1007/s10753-020-01190-4</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-9297-9871</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0360-3997 |
ispartof | Inflammation, 2020-06, Vol.43 (3), p.1054-1064 |
issn | 0360-3997 1573-2576 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7280336 |
source | Springer Link |
subjects | Adipose tissue Animals Biomedical and Life Sciences Biomedicine Caspase 1 - deficiency Caspase 1 - genetics Caspase-1 Diet, High-Fat - adverse effects Elastase Fatty liver High fat diet IL-1β Immunology Inflammasomes Interleukin-1beta - antagonists & inhibitors Interleukin-1beta - genetics Interleukin-1beta - metabolism Internal Medicine Leukocyte Elastase - deficiency Leukocyte Elastase - genetics Liver diseases Male Mice Mice, Inbred C57BL Mice, Knockout Neutrophils Non-alcoholic Fatty Liver Disease - genetics Non-alcoholic Fatty Liver Disease - metabolism Non-alcoholic Fatty Liver Disease - prevention & control Obesity Obesity - genetics Obesity - metabolism Obesity - prevention & control Original Original Article Pathology Pharmacology/Toxicology Proteinase Proteinase 3 Rheumatology Serine Serine Endopeptidases - deficiency Serine Endopeptidases - genetics Steatosis Transcription activation |
title | Mice Deficient in the IL-1β Activation Genes Prtn3, Elane, and Casp1 Are Protected Against the Development of Obesity-Induced NAFLD |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T04%3A45%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mice%20Deficient%20in%20the%20IL-1%CE%B2%20Activation%20Genes%20Prtn3,%20Elane,%20and%20Casp1%20Are%20Protected%20Against%20the%20Development%20of%20Obesity-Induced%20NAFLD&rft.jtitle=Inflammation&rft.au=Mirea,%20Andreea-Manuela&rft.date=2020-06-01&rft.volume=43&rft.issue=3&rft.spage=1054&rft.epage=1064&rft.pages=1054-1064&rft.issn=0360-3997&rft.eissn=1573-2576&rft_id=info:doi/10.1007/s10753-020-01190-4&rft_dat=%3Cproquest_pubme%3E2350093348%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c474t-62fd00dc3c39023c182405222ea5aebc3a71556b4a58b22c8fb75db2b81e04de3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2410649730&rft_id=info:pmid/32002713&rfr_iscdi=true |